| Citation: |
LIU Heng, YANG Ya'nan, YU Zhen. Effects of Qili Qiangxin Capsule on blood lipid metabolism and hemorheology in patients with coronary heart disease and angina pectoris[J]. Journal of Clinical Medicine in Practice, 2023, 27(7): 72-77. DOI: 10.7619/jcmp.20223441
|
To explore the clinical mechanism of Qili Qiangxin Capsule on blood lipid metabolism and hemorheology in patients with angina pectoris of coronary heart disease.
A total of 100 coronary heart disease patients with angina pectoris admitted to our hospital from April 2020 to August 2021 were recruited as the research objects. According to the principle of random grouping, they were divided into observation group and control group with 50 cases each group. The control group was treated with conventional treatment measures, and the observation group was treated with Qiliqiangxin capsule on the basis of conventional treatment. All patients had informed consent and signed an informed consent form before participating in the study. The general data of patients are counted according to the file information. The hemorheology indexes of patients before and after treatment were analyzed with automatic hemorheometer. Automatic biochemical analyzer was used to detect blood lipid of patients. The TCM syndrome score was conducted according to the Guiding Principles for Clinical Research of New Chinese Medicine, and the degree of coronary artery stenosis was analyzed through coronary artery CT and OCT examinations and images. Enzyme linked immunosorbent assay was used to detect the level of inflammation before and after treatment. The therapeutic effects of the two groups were analyzed.
After treatment, hemorheological related indexes in the two groups were lower than before treatment, and the hemorheological related indexes in the observation group were lower than those in the control group (P < 0.05). Total cholesterol (TC), triglyceride (TG) and low density lipoprotein cholesterol (LDL-C) were decreased after treatment, while high density lipoprotein cholesterol (HDL-C) was increased after treatment, and the above indexes in the observation group showed statistically significant differences compared with the control group (P < 0.05). After treatment, TCM syndrome score and coronary artery stenosis degree of the two groups were lower than before treatment, and were lower in the observation group than those in the control group (P < 0.05). After treatment, the levels of tumor necrosis factor-α (TNF-α), soluble urokinase plasminogen activator receptor (suPAR) and C-reactive protein (CRP) in the two groups were lower than before treatment, and their levels in the observation group were lower than those in the control group (P < 0.05). The total effective rate was 84.00%, which was higher than 66.00% in the control group, and the difference was statistically significant (P < 0.05).
Qili Qiangxin Capsules can significantly improve the clinical symptoms of patients with coronary heart disease and angina pectoris, reduce blood lipid levels, regulate lipoprotein metabolism disorders, improve blood rheology indicators, and reduce blood viscosity.
| [1] |
伊争伟, 李环. 黄芪注射液对冠心病心绞痛患者血液流变学、免疫功能及血脂代谢的影响[J]. 检验医学与临床, 2020, 17(12): 1681-1683, 1687. doi: 10.3969/j.issn.1672-9455.2020.12.014
|
| [2] |
PATEL J, PALLAZOLA V A, DUDUM R, et al. Assessment of coronary artery calcium scoring to guide statin therapy allocation according to risk-enhancing factors: the multi-ethnic study of atherosclerosis[J]. JAMA Cardiol, 2021, 6(10): 1161-1170. doi: 10.1001/jamacardio.2021.2321
|
| [3] |
周虹, 梁珊, 杨洁连. 化浊益心饮对冠心病PCI术后痰浊证患者血清脂质代谢紊乱及心血管不良事件的影响[J]. 现代中西医结合杂志, 2021, 30(7): 751-755. doi: 10.3969/j.issn.1008-8849.2021.07.016
|
| [4] |
牛慧君. 不同剂量阿托伐他汀降脂治疗对冠心病稳定型心绞痛患者血脂相关指标及氧化应激的影响[J]. 中国药物与临床, 2021, 21(10): 1754-1756. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC202110055.htm
|
| [5] |
CHEN Y, JIA T, YAN X, et al. Blood glucose fluctuations in patients with coronary heart disease and diabetes mellitus correlates with heart rate variability: a retrospective analysis of 210 cases[J]. Niger J Clin Pract, 2020, 23(9): 1194-1200. doi: 10.4103/njcp.njcp_529_19
|
| [6] |
ZHOU M, REN P, LI S, et al. Danhong injection attenuates high-fat-induced atherosclerosis and macrophage lipid accumulation by regulating the PI3K/AKT insulin pathway[J]. J Cardiovasc Pharmacol, 2019, 74(2): 152-161. doi: 10.1097/FJC.0000000000000691
|
| [7] |
ZOU G, ZHU J, LIU Z, et al. Detoxification and activating blood circulation decoction reduces restenosis involving the TLR4/NF-κB pathway after balloon injury[J]. Prostaglandins Other Lipid Mediat, 2019, 140: 1-8. doi: 10.1016/j.prostaglandins.2018.11.002
|
| [8] |
XUE Y, ZHANG L, ZHANG L, et al. Danshensu prevents thrombosis by inhibiting platelet activation via SIRT1/ROS/mtDNA pathways without increasing bleeding risk[J]. Phytomedicine, 2022, 104: 154271. doi: 10.1016/j.phymed.2022.154271
|
| [9] |
SHAO C L, CUI G H, GUO H D. Effects and mechanisms of Taohong Siwu Decoction on the prevention and treatment of myocardial injury[J]. Front Pharmacol, 2022, 13: 816347. doi: 10.3389/fphar.2022.816347
|
| [10] |
谢生梅, 韦妮娜, 韦娟, 等. 复方丹参滴丸治疗冠心病合并血脂代谢异常疗效及对血液黏度、血管内皮功能的影响[J]. 中华中医药学刊, 2020, 38(4): 162-165. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS202004038.htm
|
| [11] |
张娜, 史菲, 霍明艳, 等. 益心舒胶囊联合西药治疗冠心病稳定型心绞痛疗效及对红细胞分布宽度、总胆红素、平均血小板体积、尿酸水平的影响[J]. 现代中西医结合杂志, 2020, 29(8): 885-887. doi: 10.3969/j.issn.1008-8849.2020.08.023
|
| [12] |
LIU Z, LI G, MA Y, et al. The effects of aspirin with combined compound Danshen dropping pills on hemorheology and blood lipids in middle-aged and elderly patients with CHD: a systematic review and meta-analysis[J]. Front Public Health, 2021, 9: 664841. doi: 10.3389/fpubh.2021.664841
|
| [13] |
LI C, LI Q, XU J, et al. The efficacy and safety of compound Danshen dripping pill combined with percutaneous coronary intervention for coronary heart disease[J]. Evid Based Complement Alternat Med, 2020, 2020: 5067137.
|
| [14] |
YI M, LI Q, ZHAO Y, et al. Metabolomics study on the therapeutic effect of traditional Chinese medicine Xue-Fu-Zhu-Yu Decoction in coronary heart disease based on LC-Q-TOF/MS and GC-MS analysis[J]. Drug Metab Pharmacokinet, 2019, 34(5): 340-349. doi: 10.1016/j.dmpk.2019.07.004
|
| [15] |
周劲松, 钟远伦. 通心络联合倍他乐克对冠心病稳定型心绞痛患者心功能与血脂水平的影响[J]. 四川医学, 2020, 41(6): 605-609. https://www.cnki.com.cn/Article/CJFDTOTAL-SCYX202006012.htm
|
| [16] |
YANG D, YANG Z, CHEN L, et al. Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA-21 in apolipoprotein E-deficient mice[J]. J Cell Mol Med, 2020, 24(10): 5911-5925. doi: 10.1111/jcmm.15278
|
| [17] |
LI Y P, WANG C Y, SHANG H T, et al. A high-throughput and untargeted lipidomics approach reveals new mechanistic insight and the effects of salvianolic acid B on the metabolic profiles in coronary heart disease rats using ultra-performance liquid chromatography with mass spectrometry[J]. RSC Adv, 2020, 10(29): 17101-17113. doi: 10.1039/D0RA00049C
|
| [18] |
ZHAO Y, NIE S, YI M, et al. UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats[J]. J Ethnopharmacol, 2019, 241: 111908. doi: 10.1016/j.jep.2019.111908
|
| [19] |
徐红新, 周易, 刘畅. 血清FGF21水平与老年冠心病患者肥胖、糖脂代谢和冠状动脉狭窄程度的相关性分析[J]. 中国循证心血管医学杂志, 2020, 12(9): 1091-1093, 1097. https://www.cnki.com.cn/Article/CJFDTOTAL-PZXX202009019.htm
|
| [20] |
WANG Q, ZHENG B, CHEN P, et al. Leptin and PCSK9 concentrations are associated with vascular endothelial cytokines in patients with stable coronary heart disease[J]. Open Med: Wars, 2022, 17(1): 185-190. doi: 10.1515/med-2021-0400
|
| [21] |
ZHAO C, WANG W, YAN K, et al. The therapeutic effect and mechanism of qishen Yiqi dripping pills on cardiovascular and cerebrovascular diseases and diabetic complications[J]. Curr Mol Pharmacol, 2022, 15(3): 547-556.
|
| [22] |
李强, 郭壮波, 黎庆梅, 等. 芪苈强心胶囊对冠心病合并心力衰竭患者血清脂联素水平及心功能的影响[J]. 中国病理生理杂志, 2014, 30(6): 1119-1122. https://www.cnki.com.cn/Article/CJFDTOTAL-ZBLS201406033.htm
|
| [23] |
马登峰, 裴志强, 王晨, 等. 芪苈强心胶囊对冠心病慢性心力衰竭患者室性心律失常的影响[J]. 中国药物与临床, 2014, 14(4): 486-487. https://www.cnki.com.cn/Article/CJFDTOTAL-YWLC201404035.htm
|
| [24] |
ZHANG Y Y, ZHAO Z D, KONG P Y, et al. A comparative pharmacogenomic analysis of three classic TCM Prescriptions for coronary heart disease based on molecular network modeling[J]. Acta Pharmacol Sin, 2020, 41(6): 735-744.
|
| 1. |
王玉华，姜京汝，花义同，刘瑾. 数字乳腺体层合成联合超声对乳腺内结构扭曲病变的诊断价值分析. 影像研究与医学应用. 2023(06): 35-37 .
| |
| 2. |
赖苏梅. 数字乳腺断层摄影与全数字化乳腺摄影诊断乳腺病变的对比研究. 现代医用影像学. 2023(07): 1265-1268 .
| |
| 3. |
沈梓璇，刘海龙. DCE-MRI联合FFDM检查在乳腺病变定性诊断中的应用. 中国处方药. 2022(06): 145-146 .
| |
| 4. |
解丽君. X线及超声造影对乳腺导管内占位病变的鉴别诊断. 影像研究与医学应用. 2022(21): 29-31 .
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: